What do you supposed NP was referring to then in tonight’s C.C. when he said they went to FDA and asked for less restrictive measures with the screening process?
And then he said FDA complied and he expects enrollment to increase due to this.
Good post Clam. Totally agree. Follow the protocol and get the 75 patients that have the highest probability of success. As Patterson has said they have left no stone unturned. They know the profile of patient that will benefit from Leronlimab. An extra month is nothing if it means FDA approval. Do the trial as prescribed and don’t cut corners.
News 
Market Data 
Discover 
